Lipid-lowering agents are a crucial component of the global pharmaceutical market. Cambodia is no exception to this trend, with a growing market for these drugs in the country.
Customer preferences: Cambodian consumers are increasingly aware of the importance of maintaining healthy cholesterol levels. This has led to a growing demand for lipid-lowering agents in the country. Consumers are also becoming more health-conscious in general, which is driving demand for pharmaceutical products that can help them maintain good health.
Trends in the market: The lipid-lowering agents market in Cambodia is growing rapidly, driven by increasing demand for these drugs. There is a wide range of lipid-lowering agents available in the market, including statins, fibrates, and bile acid sequestrants. Statins are the most commonly prescribed lipid-lowering agents in Cambodia, due to their effectiveness and relatively low cost.
Local special circumstances: Cambodia is a developing country with a rapidly growing economy. As the country becomes more prosperous, there is a growing demand for healthcare products and services. This is driving growth in the pharmaceutical market, including the lipid-lowering agents market. However, the healthcare system in Cambodia is still developing, and access to healthcare services can be limited in some areas. This can make it difficult for some consumers to access lipid-lowering agents and other essential pharmaceutical products.
Underlying macroeconomic factors: The Cambodian economy has been growing rapidly in recent years, driven by a combination of factors including foreign investment, tourism, and exports. This has led to rising incomes and a growing middle class, which is driving demand for healthcare products and services. The government has also been investing in healthcare infrastructure, which is helping to improve access to healthcare services in the country. However, there are still significant challenges to be addressed, including improving healthcare quality and expanding access to healthcare services in rural areas.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
